Trial intelligence / Profile preview

Gabapentin premedication and bleeding/hemodynamic changes during direct laryngoscopy

IRCT201409288677N3Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin in perioperative bleeding and Cardiovascular collapse, sponsored by Guilan University of Medical Sciences. Primary endpoints: Intraoperative bleeding and Hemodynamic changes during direct laryngoscopy. Started Nov 2014; status: completed.

02

Drugs

gabapentin
03

Conditions

perioperative bleedingCardiovascular collapse

Beyond the preview

Go deeper on IRCT201409288677N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201409288677N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call